These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31184223)

  • 21. Amyloid-beta, tau, and dementia.
    Takashima A
    J Alzheimers Dis; 2009; 17(4):729-36. PubMed ID: 19542626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice.
    Tapia-Rojas C; Inestrosa NC
    J Neurochem; 2018 Feb; 144(4):443-465. PubMed ID: 29240990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression of Alzheimer's disease, tau propagation, and its modifiable risk factors.
    Takeda S
    Neurosci Res; 2019 Apr; 141():36-42. PubMed ID: 30120962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of tau pathology in the locus coeruleus (LC) in age-associated pathophysiology and Alzheimer's disease pathogenesis: Potential strategies to protect the LC against aging.
    Satoh A; Iijima KM
    Brain Res; 2019 Jan; 1702():17-28. PubMed ID: 29274876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach.
    Calabrese V; Scapagnini G; Colombrita C; Ravagna A; Pennisi G; Giuffrida Stella AM; Galli F; Butterfield DA
    Amino Acids; 2003 Dec; 25(3-4):437-44. PubMed ID: 14661103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging targets in neurodegeneration: new opportunities for Alzheimer's disease treatment?
    Rampa A; Gobbi S; Belluti F; Bisi A
    Curr Top Med Chem; 2013; 13(15):1879-904. PubMed ID: 23931436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein homeostasis, aging and Alzheimer's disease.
    Morawe T; Hiebel C; Kern A; Behl C
    Mol Neurobiol; 2012 Aug; 46(1):41-54. PubMed ID: 22361852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired Wnt Signaling in the Prefrontal Cortex of Alzheimer's Disease.
    Folke J; Pakkenberg B; Brudek T
    Mol Neurobiol; 2019 Feb; 56(2):873-891. PubMed ID: 29804228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Comprehensive Review of Alzheimer's Association with Related Proteins: Pathological Role and Therapeutic Significance.
    Kumar D; Sharma A; Sharma L
    Curr Neuropharmacol; 2020; 18(8):674-695. PubMed ID: 32172687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):853-866. PubMed ID: 28981597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular genetics of Alzheimer's disease and aging.
    Cacabelos R; Fernandez-Novoa L; Lombardi V; Kubota Y; Takeda M
    Methods Find Exp Clin Pharmacol; 2005 Jul; 27 Suppl A():1-573. PubMed ID: 16470248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoporosis in neurodegeneration.
    Roos PM
    J Trace Elem Med Biol; 2014 Oct; 28(4):418-21. PubMed ID: 25220531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of Aldh2 (-/-) mice as an age-related model of cognitive impairment and Alzheimer's disease.
    D'Souza Y; Elharram A; Soon-Shiong R; Andrew RD; Bennett BM
    Mol Brain; 2015 Apr; 8():27. PubMed ID: 25910195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
    Cheng XR; Zhou WX; Zhang YX
    Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the cause of sporadic Alzheimer's disease.
    Zetterberg H; Mattsson N
    Expert Rev Neurother; 2014 Jun; 14(6):621-30. PubMed ID: 24852227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dkk1: A promising molecule to connect Alzheimer's disease and osteoporosis.
    Guo X; Tang P; Liu P; Liu Y; Chong L; Li R
    Med Hypotheses; 2016 Mar; 88():30-2. PubMed ID: 26880631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibronectin type III domain-containing protein 5 interacts with APP and decreases amyloid β production in Alzheimer's disease.
    Noda Y; Kuzuya A; Tanigawa K; Araki M; Kawai R; Ma B; Sasakura Y; Maesako M; Tashiro Y; Miyamoto M; Uemura K; Okuno Y; Kinoshita A
    Mol Brain; 2018 Oct; 11(1):61. PubMed ID: 30355327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early Evidence of Low Bone Density and Decreased Serotonergic Synthesis in the Dorsal Raphe of a Tauopathy Model of Alzheimer's Disease.
    Dengler-Crish CM; Smith MA; Wilson GN
    J Alzheimers Dis; 2017; 55(4):1605-1619. PubMed ID: 27814296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease?
    Leuner K; Hauptmann S; Abdel-Kader R; Scherping I; Keil U; Strosznajder JB; Eckert A; Müller WE
    Antioxid Redox Signal; 2007 Oct; 9(10):1659-75. PubMed ID: 17867931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
    Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
    EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.